, 2005), which posits that bacterial biofilms associated with chr

, 2005), which posits that bacterial biofilms associated with chronic infections are composed of multiple strains of a single species (as well as often being polymicrobial or polykingdom communities) and that real-time HGT among the component strains (and species) leads to the continuous generation of a cloud of new strains with a novel combinations

of genes, thereby providing the bacterial community with a means to thwart the adaptive immune response of the host. Bacterial HGT is defined as the movement of genes (almost always in a unidirectional manner) between two, often unrelated, bacterial GDC-0199 ic50 cells. It is important to understand that the donor cell from which the horizontally transferred DNA arose does not have to be viable at the time of HGT, and in fact, is definitely not the case in two of the three major HGT mechanisms used by bacterial species. HGT mechanisms usually result in the Ganetespib cell line transfer of one or more relatively small blocks of donor DNA into the recipient cell and thus provide for only the partial replacement of the receiving bacterium’s chromosome. The mean sizes of horizontally acquired gene blocks for those species such as Haemophilus influenzae, Streptococcus pneumoniae, and Staphylococcus aureus that have been studied extensively are usually only between 1 and 2 kb (Hiller et al., 2007; Hogg et al., 2007; Hall et al., 2010), but larger horizontally

acquired regions of 50–100 kb in size are not uncommon. Detailed comparative whole chromosomal analyses among large numbers of strains of H. influenzae (Hogg et al., 2007) and S. pneumoniae (Table 1) have revealed that, on average, each strain contains between 200 and 400 insertions/deletions

(indels) throughout their chromosome relative to other strains of the species. Thus, each chromosome is highly mosaic with respect to the origin of its own component genes, and further, each strain’s chromosome is highly unique with respect to its gene possession Niclosamide complement. In fact, gene possession differences among the strains of a species account for the vast majority of the genetic heterogeneity within a species and dwarf the number of allelic differences observed within genes (Hall et al., 2009). Exhaustive pair-wise comparisons among all of the genomically sequenced strains for each of the species H. influenzae, S. pneumoniae, S. aureus, and Gardnerella vaginalis reveal that there are 385, 407, 246, and 608 gene possession differences, respectively, on average between every pair of strains that has been sequenced within these species (Hiller et al., 2007; Hogg et al., 2007). The 12-strain G. vaginalis supragenome (pangenome) contains 2248 genes, of which only 719 are core, with the remaining 1529 genes being distributed (noncore) among the 12 strains. Thus, more than two-thirds of the species’ genes are found in only a subset of strains.

Owing to the ability of TCRs above an affinity threshold level to

Owing to the ability of TCRs above an affinity threshold level to recognize self-protein, caution must be observed, and it is therefore necessary for all TCRs that have an increased affinity to undergo extensive in vitro and in vivo screening before reaching the clinical setting. This review has described areas of basic T-cell immunology of fundamental

importance to the field of TCR gene transfer and T-cell immunotherapy. However, the ability to transfer TCRs of known affinity and specificity into human or murine T cells ‘at will’ can facilitate further studies into the critical steps of TCR pairing and assembly, antigen recognition, T-cell signalling and function of self-reactive T cells, amongst others. Current research is focused Pexidartinib chemical structure on improving the function of TCR-transduced T cells, but also on exploring buy Pembrolizumab the introduction of TCR-αβ chains into alternative T-cell subsets, such as CD4+ helper T cells,7 CD4+ CD25+ regulatory T cells47,48 and γδ T cells,29 to generate specialized antigen-specific T cells. EM and HS are members of the Scientific Advisory Board of CellMedica Ltd. “
“Genetically altered mice carrying mutations of genes encoding crucial components of the immune system and lipid metabolism have been widely used to study the role of immune responses and inflammation in atherosclerosis.

These mice are often fed a diet, with a high content of cholesterol and saturated fat in order to induce hypercholesterolemia and arterial lesions. We review the different mouse models of atherosclerosis, type of diets, and techniques to measure lipid deposition and lesion size in the arterial walls. Moreover, the methods used to determine the presence of the immune cells in atherosclerotic lesions are also described here. Curr. Protoc.

Immunol. 96:15.24.1-15.24.23. © 2012 by John Wiley & Sons, Inc. “
“Over the past 10 years we have made great strides in Depsipeptide supplier our understanding of T helper cell differentiation, expansion and effector functions. Within the context of T helper type 2 (Th2) cell development, novel innate-like cells with the capacity to secrete large amounts of interleukin-5 (IL-5), IL-13 and IL-9 as well as IL-4-producing and antigen-processing basophils have (re)-emerged onto the type 2 scene. To what extent these new players influence αβ+ CD4+ Th2 cell differentiation is discussed throughout this appraisal of the current literature. We highlight the unique features of Th2 cell development, highlighting the three necessary signals, T-cell receptor ligation, co-stimulation and cytokine receptor ligation. Finally, putting these into context, microbial and allergenic properties that trigger Th2 cell differentiation and how these influence Th2 effector function are discussed and questioned.

RNA was reverse-transcribed using Moloney murine leukaemia virus

RNA was reverse-transcribed using Moloney murine leukaemia virus reverse transcriptase (Invitrogen Corporation, Carlsbad, CA). Complementary DNA was amplified as follows: denaturation at 94° for

50 seconds, annealing at 57° for 50 seconds, and extension at 72° for 50 seconds. Human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a control to ensure equal sample loading. Primers used were as follows: for IL-15Rα, 5′-GTCAAGAGCTACAGCTTGTAC-3′ and 5′-CATAGGTGGTGAGAGCAGTTTTC-3′; for IL-2Rα, 5′-AAGCTCTGCCACTCGGAACACAAC-3′ and 5′-TGATCAGCAGGAAAACACAGC-3′; for IL-2Rβ, 5′-ACCTCTTGGGCATCTGCAGC-3′ and 5′-CTCTCCAGCACTTCTAGTGG-3′; for IL-2Rγ, 5′-CCAGAAGTGCAGCCACTATC-3′ PF-562271 mouse and 5′-GTGGATTGGGTGGCTCCAT-3′; Fluorouracil supplier and for GAPDH, 5′-CCCTCCAAAATCAAGTGGGG-3′ and 5′-CGCCACAGTTTCCCGGAGGG-3′. For cell division experiments, FDCs (1 × 107 cells/ml) were labelled with carboxyfluorescein succinimidyl ester (CFSE; Sigma, 0·2 μm in phosphate-buffered saline) and incubated at 37° for 10 min. Cold

CFS was added to stop staining, and labelled cells were next washed twice with culture media. After 3 days of culture, CFSE intensity was measured using a FACSCalibur™ flow cytometer and analysed using flowjo software (Ashland, OR). The apoptosis assay employed staining with Annexin V and 3,3′-dihexyloxacarbocyanine iodide [DiOC6(3); Molecular Probes, Eugene, OR]. The FDCs (1 × 106 cells/ml) suspended in 100 μl of Annexin V binding buffer [0·1 m HEPES/NaOH (pH 7·4), 1·4 m NaCl, 25 mm CaCl3] were stained with 5 μl Annexin V-APC Acesulfame Potassium and 5 μl propidium iodide (BD Biosciences). Cells were incubated for 15 min at 25° in the dark. The same number of cells was employed for DiOC6(3) staining; 20 μl 8 μm DiOC6(3) was added, followed by incubation for 10 min. Samples were analysed on a FACSCalibur™ running cellquest-pro® programs (BD Biosciences). Follicular DCs at passages 4–9 were used in experiments. For FACS analysis, FDCs were collected using Enzyme-free Cell Dissociation Solution

(Specialty Media, Philipsburg, NJ). All FACS staining for surface CD14, CD44, CD54 and CD106 detection was performed as follows. Briefly, cells were washed in cold FACS buffer [0·05% (v/v) FCS, 0·01% (w/v) NaN3 in phosphate-buffered saline] and subsequently incubated with the appropriate concentration of anti-CD14, anti-CD44, anti-CD54 or anti-CD106 mAbs for 15 min at 4°. After washing with cold FACS buffer, cells were fixed in 1% (v/v) paraformaldehyde. Subsequently, samples were analysed on a FACSCalibur™ running cellquest-pro® program (BD Biosciences). Follicular DCs at passages 4–9 were seeded at 2 × 104 cells/well in 24-well plates. The next day, the medium was changed and a combination of reagents was added as indicated in the legend to Fig. 4. The concentration of each reagent was as follows: anti-IL-15 mAb (100 ng/ml), mouse IgG1 (100 ng/ml), GC-B cells (2 × 105 per well), TNF-α (10 ng/ml), IL-2 (30 U/ml), IL-4 (50 U/ml) and CD40L (100 ng/ml).

[91, 92] This C20:2 induced shorter duration of type I NKT cells

[91, 92] This C20:2 induced shorter duration of type I NKT cells in the anergic state promotes the more rapid induction of tolerogenic DCs in an IL-10-dependent manner, gives rise to reduced type I NKT cell

death, and enables C20:2-stimulated type I NKT cells to elicit enhanced protection from type 1 diabetes. These findings suggest that C20:2 may be more effective for disease intervention than αGalCer for protection from type 1 diabetes. It is anticipated XL765 cost that further support for this possibility could be obtained by more informative in vivo imaging studies of the dynamics and kinetics of interaction between type I NKT cells and DCs in pancreatic lymph nodes of NOD mice treated in vivo with either αGalCer or C20:2. In addition, 2P imaging in vivo of differentially activated and anergic NKT cells will further elucidate how a short versus long duration of NKT cell anergy can regulate poor versus strong protection from type 1 diabetes. In a second model, 2P imaging may offer more insight into whether C24:0 sulphatide activates type II NKT cells to enter into and exit from anergy more rapidly than C16:0 sulphatide activation and thereby yield less type II NKT cell death and increased GDC-0068 ic50 protection from T1D.[89] Finally, a third model is based on the report that activation of sulphatide-reactive type II NKT cells and DCs elicits the IL-12- and macrophage inflammatory protein

2-dependent recruitment of type I NKT cells into the liver.[62] The latter recruited type I NKT cells are anergic and prevent concanavalin A (Con A) -induced hepatitis by specifically blocking effector pathways, including the cytokine burst and neutrophil recruitment following Con A injection. Hepatic DCs from IL-12+/+ but not from IL-12−/− mice can adoptively transfer type I NKT cell anergy into recipient mice. Hence, IL-12 secretion by DCs enables them to induce anergy in type I NKT cells. These data describe a novel mechanism by which type II NKT cell–DC interactions in the liver can cross-regulate the activity of type I NKT cells. Further in vivo imaging analyses may help

to demonstrate whether this type of immune cross-regulation applies to human NKT cell subsets. If this is L-NAME HCl the case, such studies may facilitate immune intervention in inflammatory and autommmune diseases in humans. The ability to detect intracellular signalling that occurs during T-cell–DC contacts by 2P imaging in vivo has dramatically improved our understanding of cellular communication during immune responses.[51, 54] While a brief contact of T cells with antigen-bearing DCs induces T cells to pause momentarily and then continue their migration, these T-cell–DC interactions also induce Ca2+ signalling in T cells that promptly reduces T-cell motility. The Ca2+ signals may synergize with other signalling pathways to stimulate T-cell gene expression, cytokine secretion and proliferation.

The bands observed in the CSF of the

The bands observed in the CSF of the Selleckchem STA-9090 control dogs had a homogeneous intensity, whereas the bands observed in the CSF

of the infected animals presented remarkable variation. We detected the latent form of MMP-2 (72 kDa) in all dogs of both groups. However, only 24·0% (12/50) of the infected dogs and 60·0% (6/10) of the uninfected ones presented bands indicative of active MMP-2 (66 kDa). The level of the latent MMP-2 was significantly different between the infected and uninfected dogs (P = 0·0041) and no difference regarding the active MMP-2 was noticed (P = 0·3285). In contrast, both the latent (92 kDa) and the active (86 kDa) forms of MMP-9 were detected in some infected dogs, and no activity was observed in the www.selleckchem.com/products/E7080.html control group

(P = 0·0005 and P = 0·0003, respectively). The latent form of MMP-9 was detected in 34·0% (17/50), whereas the active MMP-9 was found in 32·0% (16/50) of the infected dogs (Figure 2). Although MMP-9 has not been detected in all the infected dogs, in the animals which this enzyme was present, there was observed a moderate positive correlation (P < 0·0001) between the latent and active forms (Figure 3). Regarding MMP-2, no correlation was noticed. From the 50 infected dogs, 17 animals were classified as asymptomatic; 12 were classified as oligosymptomatic (one or more mild and/or localized symptom) and 21 dogs were designed as symptomatic (one or more severe and/or diffuse symptom). Terminal deoxynucleotidyl transferase When these three subgroups were compared, there was still no difference among them regarding any forms of MMPs (Figure 4). In this study, the latent and active forms of MMP-9 were detected in the CSF of some dogs with VL, but not in the CSF of uninfected dogs, and, surprisingly, in the infected dogs, it was noted a decrease in both active and latent forms of MMP-2 in comparison with the control dogs. It has been previously reported that the latent and active forms of MMP-9 are present in the CSF and brain of dogs only during inflammation (13–15). In a study using

dogs with acute spinal cord injury because of intervertebral disc disease, MMP-2 was detected in all the animals and frequently detected MMP-9 in dogs with paraplegia (14). Paraparesis and paraplegia are also the most common neurological alterations in dogs with VL (2). Therefore, VL should be included in the differential diagnosis for all patients presented with neurological involvement, including infectious, neoplastic and traumatic diseases. During bacterial meningitis, MMP-9 mRNA within the CSF was elevated in 10–100 times, while MMP-2 mRNA was kept in basal levels (16). Additionally, it was noticed a positive correlation between the latent and active forms of MMP-9, and, even if this correlation was moderate, it is indicative of MMP-9 activation within the CSF.

25 In contrast, five studies have failed to find an association b

25 In contrast, five studies have failed to find an association between elevated pre-transplant sCD30 levels and the development of rejection.25–29 The reason for this discrepancy

is not clear, although it is possible that these studies were underpowered for the outcomes of interest. The use of post-transplant sCD30 measurement has also been investigated. Three studies have demonstrated significantly elevated sCD30 concentrations in kidney transplant recipients with acute rejection.26,56,57 Additionally, it has been shown that sCD30 concentrations on days 3–5 post-transplantation allows differentiation of those who subsequently develop acute rejection from those who subsequently develop acute tubular necrosis or have an uncomplicated course.21,27,30 A separate study has shown that 1-year sCD30 concentrations

can Akt inhibitor differentiate graft deterioration from chronic allograft nephropathy.28 Most of the effector functions of immune cells depend on cellular Lumacaftor ic50 energy supply.31 Thus, measurement of intracellular adenosine triphosphate (ATP) concentrations in CD4+ cells has been tried as a means of measuring immune response. This methodology requires overnight incubation of whole blood with PHA, separation of CD4+ cells via use of monoclonal anti-CD4+ antibody-coated magnetic particles, and then addition of a lysing agent to release intracellular ATP.31 In the presence of ATP, the enzyme luciferase catalyzes the oxidation of luciferin with concomitant emission of yellow-green light, which can be measured by scintillation counters or luminometers. Based on data from a multicentre study showing significantly lower CD4+ ATP concentrations in organ transplant recipients compared with healthy controls,31 an assay for ATP quantification (Cylex immune cell function assay, Cylex Inc.,

Columbia, MD, USA) was approved by the Food and Drug Administration in 2002 for use in immunosuppressed individuals.58 Clinical relevance of CD4+ ATP concentrations has been subsequently demonstrated, with studies correlating high pre-transplant ATP levels with rejection,32–34 and 17-DMAG (Alvespimycin) HCl low levels with infection such as polyoma virus.32,34,35 A meta-analysis of observational studies involving 504 solid organ transplant recipients showed that only 5% of recipients with ATP concentrations between 130 and 450 ng/mL experienced either infection or rejection.34 The intersection of the odds ratio curves for infection and rejection was found to occur at an ATP concentration of 280 ng/mL; thus, this value was proposed as a target value when using this test to guide immunosuppressant therapy. Table 5 summarizes the literature on ex vivo studies of intracellular ATP concentrations in kidney transplant recipients. It is unlikely that any single measure of immune function will be able to fully characterize overall immune status.

leprae, T

cells and B cells to the relatively increased I

leprae, T

cells and B cells to the relatively increased IgM observed in L-lep lesions. The expression of IL-5 and B-cell markers and of functional genes in L-lep lesions is consistent with the overall T helper type 2 cytokine pattern in L-lep lesions compared with T-lep lesions,3 as well as the elevated systemic humoral response that is prominent in L-lep patients.13,14 The polar L-lep and T-lep clinical presentations correlate with the level of cell-mediated immunity against M. leprae, as well as the cytokine patterns in the skin lesions, with Th2 cytokines (IL-4, IL-5 and IL-10) expressed in L-lep lesions and Th1 cytokines (IL-2 JAK inhibitor and IFN-γ) in T-lep lesions [2–4]. In fact, type 2 cytokines such as IL-4 and IL-10 have negative immunoregulatory roles in the context of infection [5, 6], and antibody responses are greater in lepromatous patients, suggesting that humoral immunity is not protective. Linking the gene expression data at the site of disease,3,10 our in vitro data suggest that the effects of IL-5 on increased IgM secretion from B cells requires the presence of T cells, because only PBMC, but not purified B cells, resulted in increased IgM in response to IL-5 (Fig. 7).

Although several in vitro studies have shown that IL-5 enhances IgA production by activated B cells either alone or with transforming growth factor-β, we did not observe any statistically significant enhancement of IgA production in cultures supplemented with IL-5.15–18 However, TGF-b1 Akt inhibitor gene expression is increased in L-lep versus T-lep lesions (fold change 1.9, P < 0.005), which may provide a mechanism for the comparatively increased IgA detected in the L-lep lesions. In addition, Mizoguchi et al.19 showed that IL-5 can elicit the maturation of CD40-activated B cells to

IgM-secreting cells in LPS-activated B cells. Lastly, Bertolini et al. showed that IL-5 can augment Staphylococcal A Cowan I strain-stimulated purified human B lymphocytes to produce IgM, but not IgA or IgG, and our result suggesting a T-cell requirement is consistent with their finding that IL-5 effects are enhanced in co-operation with IL-2.20,21 The presence of B cells in leprosy tissue was initially Non-specific serine/threonine protein kinase described by Ridley.22 Subsequently, B cells were identified by the expression of CD20 (cell surface marker for immature and mature circulating B cells), CD79 (associates with the B-cell receptor complex), and CD138 (cell surface marker for plasma cells) in active lesions from L-lep patients.23 Consistent with our gene expression data, we found that B cells, and specifically plasma cells, are expressed at the site of infection in leprosy and are 15% more abundant in L-lep lesions than in T-lep lesions. We were able to demonstrate by immunolabelling that surface IgM and IgA were consistently expressed within L-lep lesions.

BabA-Leb binding intensity by radioimmunoassay with 125I-labelled

BabA-Leb binding intensity by radioimmunoassay with 125I-labelled conjugate showed a variation among individual H. pylori strains (18, 19). Marked heterogeneity in babA genetic content and BabA expression among H. pylori strains has been reported (19, 26). Regarding the relationship between the status of babA2 and BabA adhesion, 44% of babA2-negative strains were bound to Leb in Sweden, while 45% of babA2-positive strains showed no binding capacity to Leb in Portugal (23), possibly due to uncertain PCR detection with a single primer. We determined the status of babA2 by PCR with two primer pairs. babA2-positive or -negative

strains were each defined as being positive or negative by all primer

pairs. Where a contradiction was found, the PCR amplicons buy Cobimetinib were subjected to sequence analysis to confirm the babA2 sequence. Evaluation for both BabA MBS and the subtle difference in the BabA amino acid sequence (middle region (AD1–5)) might allow determination of the extent of the BabA functional adhesion (18). Thus, the alignment of BabA sequences was analyzed in HPK5 and 20 randomly chosen isolates. The sequence analyses showed that the diversity of the BabA middle region was not a determinant of the degree of BabA-MBS, which is consistent with a previous report (24). Interestingly, selleck chemicals llc the prevalence of AD2 (90.5%) was considerable greater than that reported previously (45.5%) (24), indicating that variation of the BabA middle region might exist within Japan. SabA is a prerequisite for the non-opsonic activation of human neutrophils (27), evokes a strong inflammatory response in human neutrophils (28) and has been identified as the sialic acid-dependent hemagglutinin based on sialidase-sensitive hemagglutination (29), suggesting that SabA is a candidate virulence molecule. However, the evidence explaining the association of SabA and its pathogenesis is not enough. SabA expression is regulated by CT-dinucleotide

repeats and the number of CT repeats depends on environmental conditions (5, Cell press 17). Although the interaction between host sialyl-Lewis x and H. pylori SabA determines the degree of bacterial colonization in patients lacking gastric Leb, the sequence of the sabA gene, irrespective of CT repeats, is not a reliable predictor of SabA expression (30). Thus, the status of both babA2 and sabA genes does not always reflect these functions, implying that it is critical to evaluate the functional binding efficacy of BabA and SabA. The Leb-nonbinding strain with weak expression of BabA, but not the Leb-binding strain with strong expression of BabA, is associated with more severe mucosal injury and worse clinical outcome, suggesting that in vitro binding activity does not accurately reflect in vivo effects (19).

In the latter model, both LXRα and -β isoforms were involved [48]

In the latter model, both LXRα and -β isoforms were involved [48]. Yet, in this model, LXR activation reduced the expression of Skp2 and cyclin D1. Importantly, these effects were obtained with synthetic LXR agonists as well as with naturally occurring oxysterols. Similar results have also been reported in T- and B-CLL cell growth [29]. In T-CLL lines, Geyeregger et al. reported that LXR activation inhibits retinoblastoma protein phosphorylation and downregulates the expression of the cyclin B protein. In B-CLL cells, LXR activation was found to inhibit the expression of Bcl2 and MMP-9, thus reducing cell viability [29]

(Fig. 2A). The levels of circulating cholesterol were found to be higher n Lxra−/−Lxrβ−/− mice fed with a high-cholesterol diet than in selleck inhibitor WT control mice. This resulted in cholesterol ester accumulation and development of prostatic intraepithelial neoplasia [49]. The accumulation of cholesterol esters, due to decreased expression of the transporter in charge of cholesterol efflux (i.e., ABCA1) and increased expression of the low density lipoprotein receptor in the absence of LXR

signaling, was linked to the increased expression of the histone methyl transferase enhancer of zeste homolog 2 . Enhancer of zeste homolog 2 increased the methylation of lysine 27 of histone H3 (H3K27) on the promoters of the tumor suppressor genes beta-microseminoprotein GSK-3 inhibitor (Msmb) and homeobox protein NKX3.1 (Nkx3.1), whose expression turned out to be downregulated. The downregulation of the above-mentioned tumor suppressor genes, mediated by the accumulation of cholesterol esters in the absence

of LXR signaling, could be responsible for prostate tumorigenesis [49]. Differently from the previous model, LNCaP prostate CYTH4 tumor cells stimulated with synthetic LXR agonists showed G1 to S-phase cell cycle arrest through the suppression of Skp2 [50], as reported for breast and colon cancer cells. Furthermore, LXR activation also promotes apoptosis of LNCaP cells through the disruption of the signaling mediated by lipid rafts [51]. This mechanism relies on the reduction of both membrane cholesterol content and phosphorylated fraction of AKT associated with lipid rafts. Of note, these effects are also active in vivo in immunodeficient mice xenografted with LNCaP cells and treated with synthetic LXR agonists [51]. In GBM, it has been shown that EGFRvIII promotes tumor survival through PI3K/sterol response element-binding protein-1-dependent upregulation of low density lipoprotein receptor (LDLR) [52]. The growth of GBM was inhibited in vivo by synthetic LXR agonist treatment, which caused inducible degrader of LDLR-mediated LDLR degradation and increased expression of the ABCA1 transporter [52].

Furthermore, pre-incubation with linopirdine reduced forskolin (c

Furthermore, pre-incubation with linopirdine reduced forskolin (cAMP activator)-induced vasorelaxation ACP-196 in basilar while not altering forskolin-induced vasorelaxation of the LAD, suggesting that Kv7 channels play a more prominent role in the cerebral than coronary circulation. Consistent with the vessel data, whole cell Kv7 currents in cerebral VSMCs were potentiated by retigabine and inhibited by linopirdine,

while these responses were blunted in coronary VSMCs. This study provides evidence that mouse Kv7 channels may contribute differently to regulating the functional properties of cerebral and coronary arteries. Such heterogeneity has important implications for developing novel therapeutics for cardiovascular dysfunction. This article is protected by copyright. All rights reserved. “
“Please cite this paper as: Li X, Song Y, Han Y, Wang D, Zhu Y. Liver X receptor agonist selleck chemicals llc alleviated high glucose-induced endothelial progenitor cell dysfunction via inhibition of reactive oxygen species and activation of AMP-activated protein kinase. Microcirculation 19: 547–553, 2012. Objective:  Liver X receptors (LXRs) are key regulators of cholesterol

homeostasis. Synthetic LXR agonists are anti-atherogenic and anti-inflammatory. However, the effect of LXR agonists on endothelial progenitor cell (EPC) function is largely unknown. Here, we explored the effect of the LXR agonist TO901317 (TO) on EPC biology and the underlying mechanisms. Methods:  diglyceride Endothelial progenitor cells were cultured in mannitol or 30 mm glucose (high glucose) for 24 hours. For TO treatments, cells were pretreated with TO (10 μm) for 12 hours, then mannitol or high glucose was added for an additional 24 hours. EPCs

function, reactive oxygen species (ROS) release, and phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) were analyzed. Results:  TO could restore the high glucose-impaired adhesion and migration capacity of EPCs. High glucose impaired EPC-mediated angiogenesis, and TO reversed the impairment. TO also alleviated ROS release induced by high glucose. Western blot analysis revealed that high glucose downregulated the phosphorylation of AMPK and endothelial nitric oxide synthase, which could be reversed with TO treatment. Furthermore, inhibiting AMPK activation by compound C could abolish the protective effects of TO on EPCs. Conclusions:  TO had a protective effect on EPCs under high glucose by inhibiting ROS release and activating AMPK. “
“To test the hypothesis that Ca2+ responses to GPCR activation are coordinated between neighboring ECs of resistance arteries. EC tubes were freshly isolated from superior epigastric arteries of C57BL/6 mice. Intercellular coupling was tested using microinjection of propidium iodide. Following loading with fluo-4 dye, intracellular Ca2+ responses to ACh were imaged with confocal microscopy.